Pharmicell Co., Ltd.

18 clinical trials · Sponsor

Record	Firm	Date
Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction (NCT07431008)	Pharmicell Co., Ltd.	2024-12-26
Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study (NCT05096182)	Pharmicell Co., Ltd.	2022-03-10
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration (NCT07400458)	Pharmicell Co., Ltd.	2022-03-03
Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease (NCT05042206)	Pharmicell Co., Ltd.	2021-11-24
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study (NCT05093881)	Pharmicell Co., Ltd.	2021-08-24
Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC-PC) (NCT04615845)	Pharmicell Co., Ltd.	2021-06-21
Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC) (NCT04614051)	Pharmicell Co., Ltd.	2021-03-30
Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis (NCT04689152)	Pharmicell Co., Ltd.	2021-03-02
A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia (NCT02477540)	Pharmicell Co., Ltd.	2019-12-01
Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC (NCT03838250)	Pharmicell Co., Ltd.	2019-06-20
Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction (NCT03933995)	Pharmicell Co., Ltd.	2019-03-11

Track Pharmicell Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.